Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine

Volume: 91, Issue: 17, Pages: 797 - 799
Published: Oct 23, 2018
Abstract
Parkinson disease (PD) is a complex neurodegenerative disorder. Cognitive dysfunction and psychosis are leading contributors to nursing home placement.1 Psychosis onset is associated with cognitive decline, levodopa supplementation, and visual dysfunction.2 Treatment of PD psychosis (PDP) centers on levodopa dose adjustment, use of second-generation antipsychotics (SGAs), and cholinesterase inhibitors. SGAs function via serotonergic modulation...
Paper Details
Title
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
Published Date
Oct 23, 2018
Journal
Volume
91
Issue
17
Pages
797 - 799
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.